Imatinib, sold under the brand names Gleevec and Glivec, used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Due in large part to the development of Gleevec and related drugs having a similar mechanism of action, the five year survival rate for people with chronic myeloid leukemia nearly doubled from 31% in 1993 (before Gleevec’s 2001 FDA approval) to 59% for those diagnosed between 2003 and 2009.Median survival for imatinib-treated people with gastrointestinal stromal tumors (GIST) is nearly 5 years compared to 9 to 20 months in the pre-imatinib-era.
- ProName: Imatinib Manufacturer/High quality/Bes…
- CasNo:152459-95-5
- Molecular Formula: C29H31N7O
- Appearance: White to off-white crystalline or pale…
- Application: It is an important raw material and in…
- DeliveryTime: prompt
- PackAge: according to the clients requirement
- Port: Shanghai
- ProductionCapacity: 1-100 Metric Ton/Month
- Purity: 99%
- Storage: Store in dry, dark and ventilated plac…
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
No comments:
Post a Comment